Related Experiment Videos
Mirtazapine: a newer antidepressant
1York Health System, Pennsylvania, USA.
American Family Physician
|January 26, 1999
Summary
Mirtazapine, a noradrenergic and serotonergic antidepressant, is effective for depression, with sedation as a common side effect. While rare agranulocytosis is a serious risk, mirtazapine offers benefits for anxiety, insomnia, and sexual side effects.
Area of Science:
- Pharmacology
- Neuroscience
- Psychiatry
Background:
- Mirtazapine is a newer antidepressant with dual noradrenergic and serotonergic activity.
- It demonstrates comparable efficacy to older antidepressants in treating mild to severe depression.
Purpose of the Study:
- To evaluate the efficacy and safety profile of mirtazapine in depression treatment.
- To position mirtazapine within the context of existing antidepressant therapies.
Main Methods:
- Clinical efficacy and side effect data were reviewed.
- Comparative analysis with older antidepressant classes was performed.
Main Results:
- Mirtazapine is as effective as older antidepressants, with sedation being the most frequent side effect.
- Agranulocytosis is a rare but serious adverse event, typically reversible upon discontinuation.
- Mirtazapine is relatively safe in overdose and beneficial for patients with sexual dysfunction, anxiety, or insomnia.
Conclusions:
- Mirtazapine is a viable second- or third-line treatment option, especially when older antidepressants are ineffective or not tolerated.
- Its unique side effect profile makes it suitable for specific patient populations.
- Further establishment of its role in US depression care is pending.